AU2001267165A1 - Prevention and treatment of mycoplasma-associated diseases - Google Patents

Prevention and treatment of mycoplasma-associated diseases

Info

Publication number
AU2001267165A1
AU2001267165A1 AU2001267165A AU6716501A AU2001267165A1 AU 2001267165 A1 AU2001267165 A1 AU 2001267165A1 AU 2001267165 A AU2001267165 A AU 2001267165A AU 6716501 A AU6716501 A AU 6716501A AU 2001267165 A1 AU2001267165 A1 AU 2001267165A1
Authority
AU
Australia
Prior art keywords
mycoplasma
prevention
treatment
associated diseases
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001267165A
Inventor
Maria De Lourdes Higuchi
Sergio Schenkman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001267165A1 publication Critical patent/AU2001267165A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01018—Exo-alpha-sialidase (3.2.1.18), i.e. trans-sialidase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
AU2001267165A 2000-07-03 2001-07-03 Prevention and treatment of mycoplasma-associated diseases Abandoned AU2001267165A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
BR0002989-0A BR0002989A (en) 2000-07-03 2000-07-03 Anti-mycoplasma medication and its associations with other infectious agents
BRPI0002989-0 2000-07-03
BRNOTGIVEN 2001-07-03
PCT/BR2001/000083 WO2002002050A2 (en) 2000-07-03 2001-07-03 Prevention and treatment of mycoplasma-associated diseases

Publications (1)

Publication Number Publication Date
AU2001267165A1 true AU2001267165A1 (en) 2002-01-14

Family

ID=3944635

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001267165A Abandoned AU2001267165A1 (en) 2000-07-03 2001-07-03 Prevention and treatment of mycoplasma-associated diseases

Country Status (3)

Country Link
AU (1) AU2001267165A1 (en)
BR (1) BR0002989A (en)
WO (1) WO2002002050A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003082324A1 (en) * 2002-03-28 2003-10-09 Maria De Lourdes Higuchi Prevention and treatment of mycoplasma-associated diseases
US8822232B2 (en) 2003-03-28 2014-09-02 Maria De Lourdes Higuchi Diagnosis, prevention and treatment of disorders characterized by undesirable cell proliferation
US7732410B2 (en) 2003-03-28 2010-06-08 Higuchi Maria De Lourdes Compositions for inhibiting atherosclerosis
US7674832B2 (en) 2003-03-28 2010-03-09 Higuchi Maria De Lourdes Compositions for promoting wound healing and treating psoriasis
BRPI1004987A2 (en) 2010-11-26 2013-03-26 Maria De Lourdes Higuchi prevention and treatment of mycoplasma-associated diseases

Also Published As

Publication number Publication date
WO2002002050A2 (en) 2002-01-10
BR0002989A (en) 2002-02-13
WO2002002050A3 (en) 2002-08-15

Similar Documents

Publication Publication Date Title
AU2003290548A1 (en) Prevention and treatment of synucleinopathic disease
WO2001078781A8 (en) Methods for prevention and treatment of gastrointestinal disorders
AU2002324914A1 (en) Pharmaceutical compositions of drug-oligomer conjugates and methods of treating diseases therewith
AU2001269314A1 (en) Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds
AU2002345255A1 (en) Composition comprising soy and use thereof in the prevention and/or treatment of various diseases
AU2002237667A1 (en) Methods for the treatment and prevention of urinary stone disease
AU2001256855A1 (en) Preparation for the prevention and treatment of ocular disorders
AUPQ622600A0 (en) Treatment and/or prevention of ocular pain
AU5908300A (en) Prevention and treatment of amyloid-associated disorders
AU6887101A (en) Copolymers and methods of treating prion-related diseases
AU2002231206A1 (en) Treatment of depression
AU2001259085A1 (en) Treatment of ocular neovascularization and related diseases
AUPQ344799A0 (en) Treatment of respiratory diseases and infections
AU2002220257A1 (en) Methods of treatment involving human mda-7
AU7601400A (en) Treatment and prevention of hepatic disorders
AU2001232345A1 (en) Compositions for preventing and treating digestive diseases
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2001267165A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2001245414A1 (en) Treatment of allergies
AU2000275035A1 (en) Therapeutic and prophylactic drugs of myopia
AU2002222125A1 (en) Prevention and treatment of tachyphylactic response
AU2001258575A1 (en) Treatment of cancer and neurological diseases
AU2001262741A1 (en) Medicines for the prevention and treatment of neurodegenerative diseases
AU1405001A (en) Treatment of diseases
AU3735900A (en) Methods of treatment and prevention of restenosis